Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.50 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.49 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.49 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.49 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.41 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2758516 | 1.00 | CYP2A6 (0.50) | CYP2A6GRIA1GRIA2GRIA3GRIA4 | |
| SCHEMBL26205757 | 1.00 | CYP2A6 (0.50) | CYP2A6GRIA1GRIA2GRIA3GRIA4 | |
| SCHEMBL9435111 | 0.94 | GRIA1 (0.56) | CYP2A6GRIA1GRIA2GRIA3GRIA4 | |
| SCHEMBL11527149 | 0.85 | GRIA1 (0.49) | CYP2A6GRIA1GRIA2GRIA3GRIA4 | |
| SCHEMBL11527145 | 0.85 | GRIA1 (0.49) | CYP2A6GRIA1GRIA2GRIA3GRIA4 | |
| SCHEMBL14118345 | 0.83 | MMP2 (0.49) | GRIA1GRIA2GRIA3GRIA4ALDH1A1 | |
| SCHEMBL14461703 | 0.83 | MAOB (0.57) | CYP2A6ALDH1A1NPC1RAB9AL3MBTL1 | |
| SCHEMBL18552777 | 0.83 | CYP2A6 (0.47) | CYP2A6GRIA1GRIA2GRIA3GRIA4 | |
| SCHEMBL13399794 | 0.81 | ALOX5AP (0.41) | CYP2A6GRIA1GRIA2GRIA3GRIA4 | |
| SCHEMBL21275419 | 0.81 | TAAR1 (0.54) | CYP2A6GRIA1GRIA2GRIA3GRIA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120126214-A1 | METHODS AND INTERMEDIATES FOR THE SYNTHESIS OF DIPYRRIN-SUBSTITUTED PORPHYRINIC MACROCYCLES | UNITED STATES DEPARTMENT OF ENERGY | 2012-05-24 | — | — | US | disclosed |
| WO-2007061882-A2 | PYRROLOTRIAZINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120126214-A1 | METHODS AND INTERMEDIATES FOR THE SYNTHESIS OF DIPYRRIN-SUBSTITUTED PORPHYRINIC MACROCYCLES | HCCS, PPOX, DHPS | CYP2A6 3517/4885GRIA1 2517/4885GRIA2 1898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.